Cite
TCT-166 Optimal Vessel Sizing for the Bioresorbable Scaffold Implantation and the Incidence of Scaffold Thrombosis: Insights From the COMPARE-ABSORB Trial.
MLA
Chang, Chun-Chin, et al. “TCT-166 Optimal Vessel Sizing for the Bioresorbable Scaffold Implantation and the Incidence of Scaffold Thrombosis: Insights From the COMPARE-ABSORB Trial.” Journal of the American College of Cardiology (JACC), vol. 74, no. 13, Oct. 2019, p. B165. EBSCOhost, https://doi.org/10.1016/j.jacc.2019.08.221.
APA
Chang, C.-C., Onuma, Y., Chevalier, B., West, N., Gori, T., Barbato, E., Tarantini, G., Kocka, V., Achenbach, S., Dudek, D., Escaned, J., Abdel-Wahab, M., Esposito, G., Tijssen, J., Morice, M.-C., Smits, P., & Van Geuns, R.-J. (2019). TCT-166 Optimal Vessel Sizing for the Bioresorbable Scaffold Implantation and the Incidence of Scaffold Thrombosis: Insights From the COMPARE-ABSORB Trial. Journal of the American College of Cardiology (JACC), 74(13), B165. https://doi.org/10.1016/j.jacc.2019.08.221
Chicago
Chang, Chun-Chin, Yoshinobu Onuma, Bernard Chevalier, Nick West, Tommaso Gori, Emanuele Barbato, Giuseppe Tarantini, et al. 2019. “TCT-166 Optimal Vessel Sizing for the Bioresorbable Scaffold Implantation and the Incidence of Scaffold Thrombosis: Insights From the COMPARE-ABSORB Trial.” Journal of the American College of Cardiology (JACC) 74 (13): B165. doi:10.1016/j.jacc.2019.08.221.